Flame Biosciences is a clinical-stage pioneer in the biotechnology and healthcare industries, focusing on the discovery, development, and commercialization of groundbreaking therapies for cancer and inflammatory diseases. Established in 2017, the company has garnered significant attention with its recent $100.00M Venture Round investment as of 30 September 2020.
The investment was led by a consortium of prominent investors including T. Rowe Price, Adage Capital Management, Janus Handerson, Logos Capital, Rock Springs Capital, Samsara BioCapital, Terra Magnum Capital Partners, Cormorant Asset Management, Acuta Capital Partners, and Surveyor Capital.
Flame Biosciences' steadfast commitment to pioneering therapies sets it apart as a key player in the development of transformative treatments for cancer and inflammatory diseases, making it an appealing prospect for potential investors.
-logo.jpg "Collaborative Clinical Research Solutions, Inc. (d/b/a CCRS Consultants)"){kind=logo}